Word

IOVANCECARES

Status

Dead

Status Code

606

Status Date

Monday, January 29, 2024

Serial Number

90107074

Mark Type

3000

Filing Date

Tuesday, August 11, 2020

Published for Opposition

Tuesday, November 3, 2020

Abandoned Date

Monday, January 29, 2024

Trademark Owner History

Iovance Biotherapeutics, Inc. - Owner At Publication

Classifications

9 recorded computer software, downloadable computer software and downloadable mobile applications for data analysis for immunotherapy treatments and research; recorded computer software, downloadable computer software and downloadable mobile applications for tracking and monitoring chain of custody and chain of identity of cell therapies; recorded computer software, downloadable computer software and downloadable mobile applications for scheduling and tracking medical patient appointments, medical and healthcare services and medical laboratory services, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; recorded computer software, downloadable computer software and downloadable mobile applications for processing medication reimbursement and payer assistance services, patient support services, and hospital support services; recorded computer software, downloadable computer software and downloadable mobile applications for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing referrals in the medical and healthcare fields; recorded computer software, downloadable computer software and downloadable mobile applications for messaging and chat in the medical and healthcare fields; recorded computer software, downloadable computer software and downloadable mobile applications for locating doctors, physician's assistants, nurses, nutritionists, therapists, healthcare professionals and healthcare service providers; recorded computer software, downloadable computer software and downloadable mobile applications for providing medical diagnosis, consultation, treatment recommendations, and medical care services and information; recorded computer software, downloadable computer software and downloadable mobile applications for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments

5 pharmaceuticals for the treatment of oncological disease and disorders, cancer and tumors; pharmaceutical preparations for use in immunotherapy for the treatment of oncological disease and disorders

38 telecommunications services, namely, transmission of voice, audio, data, graphics, and video between patients and healthcare providers via global and local computer networks in the fields of telehealth, telemedicine, remote care, and virtual health care services; providing users with real-time and on-demand access to health care professionals via computer, telephone, and other electronic means via telecommunication networks

36 financial administration of patient reimbursement programs; financial administration of medication reimbursement programs and services; providing information regarding pharmaceutical cost reimbursements; providing assistance to patients regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage

35 medical appointment scheduling services; confirming scheduled appointments for others in the field of cancer treatments; physician referral services; hospital referral services; providing online physician and hospital directories on the internet; processing of online orders of prescriptions

45 providing patient advocate and case management services in the field of oncology and immunotherapy treatments

44 medical services, namely, resection of tumor and modifying cells for the treatment of cancer and other diseases and medical conditions; immunotherapy treatments; medical diagnostic and treatment services; providing information in the field of oncology and immunotherapy treatments; providing medical information, consultancy and advisory services; providing a web site featuring medical information and information relating to pharmaceuticals; providing medical and health information relating to pharmaceuticals; medical, telehealth, remote care and virtual health care services, namely, providing medical services and consultation over the telephone and via the Internet through the use of personal computers, smartphones, tablets, and mobile wireless devices via video, email, or a global computer network; providing medical services, telehealth services in the nature of telemedicine services, remote health care services, and virtual health care services via a web site and mobile app featuring health and medical information; providing telemedicine and virtual health care services for the diagnosis, consultation, and treatment of oncological or immune system conditions; medical counseling; consulting services in the field of medical care; medical, immunotherapy and pharmaceutical consultation; medical analysis services for diagnostic and treatment purposes provided by medical laboratories

42 providing temporary use of non-downloadable computer software for scheduling and tracking medical patient appointments, medical laboratory services, medical procedures, and for matching patients and medical treatment sites, and for use in providing data analytics in the fields of medical research, cancer treatments and drug and immunotherapy development; providing an interactive website featuring technology that allows users to communicate with patients and manage patient treatment data, for facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care and virtual health care services; software as a service (SaaS) services featuring software for delivering streamlined medical treatment information and improving communication among stakeholders in medical treatment and medical research; software as a service (SaaS) services featuring software for tracking and monitoring chain of custody and chain of identity of cell therapies; providing medical and scientific research information in the field of drug development and medical treatment development for delivering streamlined treatment information and improving communication among stakeholders in providing medical treatment; providing medical and scientific research information in the fields of medical research and cancer treatments; providing temporary use of non-downloadable software for providing medical referrals; software as a service (SAAS) services featuring software for collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the fields of medicine, medical care, healthcare, telehealth, telemedicine, remote care, and virtual health care services; software as a service (SAAS) services featuring software for scheduling medical and healthcare services; software as a service (SAAS) services featuring software for providing consultation, and medical care services and information; providing temporary use of on-line non-downloadable software for remote medical consultation in the field of telemedicine; platform as a service (PAAS) featuring computer software platforms for online collecting, organizing, obtaining, and managing patient information, facilitating and handling communications between patients and providers, and providing advice and referrals in the medical and healthcare fields; software as a service (SAAS) services featuring software for managing the supply of tumor shippers, temperature monitors and GPS trackers provided to sites involved in the provision of immunotherapy treatments and cancer treatments

The mark consists of the word "IOVANCE" and the word "CARES," without a space between them, with a stylized "O" in "IOVANCE" consisting of a crescent shape opening to the bottom left corner and five smaller crescent shapes opening to the upper right corner; the word "IOVANCE" appears primarily in navy blue with the small crescents in shades of green to light green, with the word "CARES" appearing in green in a cleaner font.
The color(s) navy blue, green, and light green is/are claimed as a feature of the mark.

Trademark Events

Jan 29, 2024

Abandonment Notice E-Mailed - No Use Statement Filed

Jan 29, 2024

Abandonment - No Use Statement Filed

May 25, 2023

Notice Of Approval Of Extension Request E-Mailed

May 24, 2023

Sou Extension 5 Granted

May 17, 2023

Sou Extension 5 Filed

May 24, 2023

Case Assigned To Intent To Use Paralegal

May 17, 2023

Sou Teas Extension Received

Dec 14, 2022

Notice Of Approval Of Extension Request E-Mailed

Dec 12, 2022

Sou Extension 4 Granted

Dec 12, 2022

Sou Extension 4 Filed

Dec 12, 2022

Sou Teas Extension Received

Jun 4, 2022

Notice Of Approval Of Extension Request E-Mailed

Jun 2, 2022

Sou Extension 3 Granted

Jun 2, 2022

Sou Extension 3 Filed

Jun 2, 2022

Sou Teas Extension Received

Feb 23, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Feb 23, 2022

Teas Change Of Correspondence Received

Feb 23, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 23, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Feb 23, 2022

Teas Change Of Owner Address Received

Dec 18, 2021

Notice Of Approval Of Extension Request E-Mailed

Dec 16, 2021

Sou Extension 2 Granted

Dec 16, 2021

Sou Extension 2 Filed

Dec 16, 2021

Sou Teas Extension Received

May 25, 2021

Notice Of Approval Of Extension Request E-Mailed

May 21, 2021

Sou Extension 1 Granted

May 21, 2021

Sou Extension 1 Filed

May 21, 2021

Sou Teas Extension Received

Dec 30, 2020

Noa E-Mailed - Sou Required From Applicant

Nov 3, 2020

Official Gazette Publication Confirmation E-Mailed

Nov 3, 2020

Published For Opposition

Oct 14, 2020

Notification Of Notice Of Publication E-Mailed

Sep 26, 2020

Approved For Pub - Principal Register

Sep 25, 2020

Examiner's Amendment Entered

Sep 25, 2020

Notification Of Examiners Amendment E-Mailed

Sep 25, 2020

Examiners Amendment E-Mailed

Sep 25, 2020

Examiners Amendment -Written

Sep 16, 2020

Assigned To Examiner

Sep 15, 2020

Notice Of Design Search Code E-Mailed

Sep 13, 2020

New Application Office Supplied Data Entered

Aug 14, 2020

New Application Entered